Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.8K Sell
35,614
-9,957
-22% -$19K ﹤0.01% 7323
2025
Q4
$98K Buy
45,571
+42,163
+1,237% +$144K ﹤0.01% 6921
2025
Q3
$16.4K Buy
3,408
+1,596
+88% +$8.71K ﹤0.01% 8280
2025
Q2
$10.1K Sell
1,812
-568
-24% -$4.49K ﹤0.01% 8862
2025
Q1
$29.2K Sell
2,380
-2,878
-55% -$43.9K ﹤0.01% 7966
2024
Q4
$70.4K Buy
5,258
+660
+14% +$7.51K ﹤0.01% 7079
2024
Q3
$43.1K Sell
4,598
-17,971
-80% -$182K ﹤0.01% 6912
2024
Q2
$219K Buy
22,569
+17,800
+373% +$176K ﹤0.01% 5597
2024
Q1
$50.1K Buy
4,769
+114
+2% +$1.41K ﹤0.01% 6503
2023
Q4
$62.1K Buy
4,655
+2,623
+129% +$35.9K ﹤0.01% 6431
2023
Q3
$29.4K Sell
2,032
-2,369
-54% -$40.8K ﹤0.01% 6596
2023
Q2
$86.7K Buy
+4,401
New +$69.1K ﹤0.01% 6127
2023
Q1
Sell
-1,871
Closed -$19.6K 9875
2022
Q4
$19.6K Sell
1,871
-404
-18% -$3.59K ﹤0.01% 7673
2022
Q3
$12K Buy
2,275
+1,808
+387% +$13.6K ﹤0.01% 8158
2022
Q2
$4K Sell
467
-1,238
-73% -$14.4K ﹤0.01% 9068
2022
Q1
$30K Sell
1,705
-999
-37% -$31.1K ﹤0.01% 6999
2021
Q4
$155K Buy
2,704
+637
+31% +$42.5K ﹤0.01% 5910
2021
Q3
$156K Buy
2,067
+84
+4% +$8.89K ﹤0.01% 5509
2021
Q2
$334K Sell
1,983
-19
-0.9% -$3.33K ﹤0.01% 5012
2021
Q1
$351K Sell
2,002
-93
-4% -$18.8K ﹤0.01% 5114
2020
Q4
$429K Sell
2,095
-435
-17% -$80.8K ﹤0.01% 4717
2020
Q3
$494K Buy
+2,530
New +$609K ﹤0.01% 4214

Other funds holding GOCO

UBS Group's GOCO Position: Q1 2026 in Review

UBS Group reduced its GoHealth (GOCO) stake by 22% in Q1 2026, selling an estimated $19K and leaving 35,614 shares worth $53.8K. The position accounts for ﹤0.01% of the portfolio, ranked #7323.

UBS Group first reported a position in GOCO in Q3 2020 and has held it in 22 quarters since. The position peaked at $494K in Q3 2020. 67 funds tracked by Wall St. Rank hold GOCO as of Q1 2026.

  • UBS Group held 35,614 shares of GoHealth worth $53.8K as of Q1 2026.
  • UBS Group sold 9,957 GoHealth shares in Q1 2026, an estimated $19K.
  • GoHealth made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7323 holding.
  • UBS Group first reported a position in GoHealth in Q3 2020 and has held it in 22 quarters since.
  • UBS Group's GoHealth position peaked at $494K in Q3 2020.
  • 67 funds tracked by Wall St. Rank held GoHealth as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.